Roche, LabCentral Partner to Support Biotech Startups

LabCentral and Roche entered an agreement in which Roche will provide technology and financial support to LabCentral, a shared lab space designed to support high-potential life science companies and biotech startups.
 
Roche instruments will expand capacity for LabCentral resident companies performing high-throughput DNA studies and include a MagNA Pure 96 robotic workstation for automated purification of nucleic acids, LightCycler 96 Real-Time PCR system, and automated reagent freezer. 
 
“We are thrilled to welcome Roche as our newest gold sponsor,” said LabCentral’s co-founder and president, Johannes Fruehauf, M.D., Ph.D. “Having the world’s largest biotech company on our roster of supporters is a testament to LabCentral’s model designed to spur science innovation and fast-track startups to be successful and improve human health.”
 
“Translating life science research into improved ways to diagnose disease is critical to the development of personalized healthcare solutions and better patient care,” said Roche Diagnostics North America president and chief executive officer Jack Phillips. “Today, LabCentral and its resident companies are at the center of some of the most-promising healthcare research, and Roche is excited to be a part of their effort to foster this kind of innovation.”